TCR2 Therapeutics
Why Robinhood?
You can watch TCRR and buy or sell other stocks, ETFs, and their options commission-free!About TCRR
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.
TCRR Key Statistics
Stock Snapshot
As of today, TCR2 Therapeutics(TCRR) shares are valued at $1.48. The company's market cap stands at 58.11M, with a P/E ratio of -0.35.
During the trading day, TCR2 Therapeutics(TCRR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for TCR2 Therapeutics(TCRR) stock has reached 0, versus its average volume of 694.31K.
The stock's 52-week range extends from a low of $0.82 to a high of $3.88.
The stock's 52-week range extends from a low of $0.82 to a high of $3.88.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.